Navigation Links
Experimental Drug Helps Fight Aggressive Breast Cancer: Report
Date:1/6/2011

By Amanda Gardner
HealthDay Reporter

WEDNESDAY, Jan. 5 (HealthDay News) -- Researchers have taken another step in the hunt to find a treatment for an aggressive, likely-to-recur form of breast cancer.

In a study published in the Jan. 5 online edition of the New England Journal of Medicine, the experimental drug iniparib not only shrank tumors and increased the time they took to progress, but also surprised researchers by prolonging survival in women with what's known as triple-negative breast cancer.

This type of breast cancer lacks receptors for estrogen and progesterone and doesn't have large quantities of HER-2/neu protein, which the most successful cancer therapies target. This means that many currently available drugs simply won't affect it.

"We were surprised [at the results] because triple-negative breast cancer is very difficult to treat," said study lead author Dr. Joyce O'Shaughnessy.

"The big, big surprise was survival," added O'Shaughnessy, who nevertheless stressed that the trial was small and preliminary.

The findings were enough to generate the interest of Dr. Lisa A. Carey, the co-author of an accompanying editorial.

"It is early, but it's really exciting because it's a new class of drugs. It isn't that often that we have a completely new approach to treating cancer," said Carey, medical director of the University of North Carolina Breast Center in Chapel Hill. "This is a new book. We've just opened it up."

Iniparib inhibits a pathway that helps repair DNA; researchers call it the poly(ADP-ribose) polymerase (PARP) pathway. If this chain is interrupted, cancer cells don't have the necessary tools to repair themselves.

"[PARP inhibitors] work by preventing the cells from repairing damage to their DNA," Carey explained.

A similar drug, in fact, has shown benefit in patients with BRCA 1 or BRCA 2 mutations predisposing them to breast and ovari
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Experimental Drug Offers Hope for Cystic Fibrosis Patients
2. Experimental Vaccine Shields Monkeys Against Ebola
3. Experimental targeted therapy shows early promise against medulloblastomas
4. Experimental nonsteroidal treatment of asthma shows promise
5. Experimental obesity drug avoids brain effects that troubled predecessors
6. Experimental treatments for cocaine addiction may prevent relapse
7. Experimental TB Test Called Fast and Accurate
8. Experimental Drug Shows Promise for Bone Marrow Disorder
9. Experimental Leukemia Drug Proves a Slam Dunk
10. Experimental Test May Spot Prostate Cancer Earlier, More Accurately
11. Experimental Drug Aids Kids With Nervous System Tumor
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Experimental Drug Helps Fight Aggressive Breast Cancer: Report
(Date:8/4/2015)... ... August 04, 2015 , ... Lightning Labels is ... Denver facility that will usher in a new standard of sticker and label-making ... more effectively meet its twin objectives of quality and quantity without compromising the ...
(Date:8/4/2015)... ... ... Following last month’s successful rollout of its client video series, ACE announces the ... Setting, and The Importance of PVI Accreditation. , In The Benefits of Cath ... Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions in Las Vegas, NV, Chandan Devireddy, MD, ...
(Date:8/3/2015)... ... August 04, 2015 , ... ... Holt as a 2015-2016 inductee into the NAPW VIP Woman of the ... With more than 700,000 members and over 200 operating Local Chapters, NAPW is ...
(Date:8/3/2015)... ... August 04, 2015 , ... Keeping strong to their ... professionals, HomeCEUConnection.com today announced extra savings on Florida Physical Therapy continuing education ... big savings on Physical Therapy Flex packages by entering the promo ...
(Date:8/3/2015)... Indianapolis, Indiana (PRWEB) , ... August 03, 2015 ... ... ) throughout Livingston and Putnam counties. As a family owned and operated ... all septic matters. They are a leader in septic installations because of ...
Breaking Medicine News(10 mins):Health News:Lightning Labels Installs State-of-the-Art Digital Press 2Health News:Lightning Labels Installs State-of-the-Art Digital Press 3Health News:Accreditation for Cardiovascular Excellence (ACE) Clients Explain Benefits of ACE Accreditation 2Health News:Accreditation for Cardiovascular Excellence (ACE) Clients Explain Benefits of ACE Accreditation 3Health News:National Association of Professional Women Inducts Armethia Holt, CEO at AA&G Group Homes, LLC, Into its VIP Woman of the Year Circle 2Health News:Elite Online CE Provider Offers Discounted Flexible Packages to Meet Florida Physical Therapy Continuing Education Requirements 2Health News:Zeiter’s Septics Performs Affordable Septic Installations Throughout Livingston & Putnam Counties Effective Immediately 2Health News:Zeiter’s Septics Performs Affordable Septic Installations Throughout Livingston & Putnam Counties Effective Immediately 3
... that has enhanced public understanding of biomedical researchWASHINGTON, ... (FBR) announced today it is accepting entries for ... The awards, named after FBR,s late chairman, ... reporting has enhanced public understanding of how the ...
... April 3 AstraZeneca (NYSE: AZN ) ... Drug Administration (FDA) posted to its web site -- ... 8, 2009 Psychopharmacologic Drugs Advisory Committee (PDAC) meeting. The ... efficacy data provided in supplemental new drug applications (sNDA) ...
... researchers say , , FRIDAY, April 3 (HealthDay News) -- ... insights into multiple sclerosis and other afflictions of the ... looking into why pregnant cats on a special diet ... including paralysis and vision, University of Wisconsin-Madison researchers found ...
... stock jeopardize shareholder interests?TEQUESTA, Fla., April 3 In ... and the Board of Directors of Energy Partners, LTD ... (CCC), personally holding a quarter million shares as well ... concern over a proposed bond buyout of the company,s ...
... Pass Bill to Protect Patient Access WASHINGTON, April 3 ... osteoporosis testing and reduce the physical and economic burden ... "Medicare Fracture Prevention and Osteoporosis Testing Act of 2009," ... and Olympia Snowe (R-ME) introduced the Senate version and ...
... 3 First Choice Professionals, LLC., today announced the ... Health Integration Solution ( THIS ). ... has joined forces with TIBCO Software Inc. (Nasdaq: ... brokering, SOA integration, and complex event processing. The partnership ...
Cached Medicine News:Health News:Foundation for Biomedical Research Announces Michael E. DeBakey Journalism Awards 2Health News:FDA Advisory Committee Documents for SEROQUEL XR Available on AstraZeneca Web Site 2Health News:FDA Advisory Committee Documents for SEROQUEL XR Available on AstraZeneca Web Site 3Health News:FDA Advisory Committee Documents for SEROQUEL XR Available on AstraZeneca Web Site 4Health News:FDA Advisory Committee Documents for SEROQUEL XR Available on AstraZeneca Web Site 5Health News:Cat Food-Linked Illness Yields Clues to MS 2Health News:Access to Osteoporosis Testing for Americans in Jeopardy 2Health News:Access to Osteoporosis Testing for Americans in Jeopardy 3Health News:Access to Osteoporosis Testing for Americans in Jeopardy 4Health News:Access to Osteoporosis Testing for Americans in Jeopardy 5Health News:FCP Announces Total Healthcare Integration Solution (THIS) Powered by TIBCO 2
(Date:8/3/2015)... 2015  BioElectronics Corporation (OTC Pink: BIEL), maker of ... Andrew J. Whelan , President will be interviewed ... Business" at 9am EDT on Wednesday, August 5 th ... http://tunein.com/radio/Money-Matters-Boston-1120-s27548/ Mr. ... the company,s flagship product, ActiPatch Therapy, is achieving in ...
(Date:8/3/2015)... Aug. 3, 2015  CytomX, a biopharmaceutical company ... today announced the promotion of several members of ... , who previously served as vice president of ... to senior vice president of corporate development and ... positions as the vice president of business development ...
(Date:8/3/2015)... , Aug. 3, 2015 Immune Pharmaceuticals, ... CEO, Dr. Daniel Teper , will present live ... August 6, 2015 TIME:   11:30AM EDT LINK:    ... live, interactive online event where investors are invited to ... the presentation hall as well as the association,s "virtual ...
Breaking Medicine Technology:UpTick News Wire Radio Show Will Interview BioElectronics' CEO Andrew Whelan 2CytomX Announces Management Team Promotions 2CytomX Announces Management Team Promotions 3Immune Pharmaceuticals to Webcast Live at VirtualInvestorConferences.com August 6 2
... Feb. 19, 2011 Genoptix, Inc. (Nasdaq: ... a memorandum of understanding ("MOU") providing for the settlement ... the Superior Court of the State of California, San ... Genoptix, Inc., Case No. 37-2011-00050762-CU-BT-NC, (2) Schwitters v. Genoptix, ...
... 18, 2011 TLC Vision announced today its plans for ... in San Diego.  Internationally recognized as leaders in field of ... Tanzer MD will lend their surgical skill and expertise to ... center will continue to be at the forefront of working ...
Cached Medicine Technology:Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 2Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 3Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 4Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 5Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 6Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 7Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 8Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 9Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 10Genoptix Enters Into Memorandum of Understanding Related to Class Action Lawsuits 11TLC Vision Announces TLC Laser Eye Center San Diego 2
... device is a qualitative immunoassay ... inspect the,overdose usage of cocaine ... metabolite of,cocaine, in human urine ... 300 ng/mL. It is for ...
... test is an immunochromatography based one ... for qualitative determination of Benzodiazepines and ... a cut-off level of 300 ng/mL ... in the point of care location ...
... 2000, Applied Biosystems introduced the completely ... M 3100 Genetic Analyzer.,Now the innovative ... available in our new four-capillary ABI ... to-medium-throughput laboratory needs, the fully automated ...
... AcT diff2 delivers performance, ... office labs and smaller laboratories. ... that offers a small sample ... closed analysis modes, a wide ...
Medicine Products: